As voters fume about the high cost of health care, politicians have been targeting two well-deserved villains: pharmaceutical companies, whose prices have risen more than inflation, and ins
EASTON, Pa. — Walk into a big-box retailer such as Walmart or Michaels and you’re likely to see MCS Industries’ picture frames, decorative mirrors or kitschy wall décor.
Private health insurance plans in 2017 paid more than twice what Medicare would have for those same health care services, says a sweeping new study from Rand Corp., a respected research organization.
This article is for premium subscribers!
To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!
If you are a premium subscriber that is not logged in, please login now.
A legislative task force has taken a crack at attacking rising health care costs.
The pharmaceutical industry could see windfall profits from a little-noticed tweak to the insurance market tucked into the Trump administration’s draft executive order on drug prices, experts say.
OPINION -- A New York Times report released yesterday put the spotlight on healthcare prices.
OPINION -- We respectfully disagree with the July 29, 2015 article “Hospitals, Ambulatory Surgery Centers, Specialists Drive up Costs.” While healthcare costs are indeed increasing, it
How much money people have to fork over when they go to the doctor can make a big difference in how satisfied they are with their health plan, a recent study suggests.
OPINION -- On an almost daily basis these days we hear about the rising costs of healthcare and the impact on both employer and employee. In 2016, premiums are expected to rise in the double-digits in part due to ACA-imposed taxes, with much of those costs being shifted to the employee.
February 28, 2013 -- Posing this question to healthcare thought leaders, they often reject the question, as “too negative.” Is this a form of denial or lack of interest in sensitive critical thinking?
